- Tytuł:
- Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog®
- Autorzy:
- Źródło:
- In Computer Methods and Programs in Biomedicine June 2021 205
Czasopismo naukowe